Market Place
Sourcing Support
Helius Medical Technologies Announces Reverse Stock Split
30 Apr 2025 //
GLOBENEWSWIRE
Helius Medical Announces First Reimbursement for PoNS Device
11 Mar 2025 //
GLOBENEWSWIRE
Helius: PoNS Therapy® Improves Gait In Multiple Sclerosis Patients
22 Jan 2025 //
GLOBENEWSWIRE
Helius Exceeds Enrollment Goal For Stroke Pivotal Study
21 Jan 2025 //
GLOBENEWSWIRE
Helius Exercises Warrants, Raises $3.7M In Private Placement
21 Jan 2025 //
GLOBENEWSWIRE
Helius Announces First PoNS® Sale to VA Healthcare System
23 Dec 2024 //
GLOBENEWSWIRE
Helius Medical Explores Strategic Alternatives
18 Nov 2024 //
GLOBENEWSWIRE
Helius Medical Updates on PoNS® Device Market Access Efforts
18 Nov 2024 //
GLOBENEWSWIRE
Helius Medical Technologies To Present At ThinkEquity Conference
18 Oct 2024 //
GLOBENEWSWIRE
Helius Medical Announces CMS Reimbursement Updates For PoNS
14 Oct 2024 //
GLOBENEWSWIRE
Helius Medical Reports Positive PoNSTEP Study Results
30 Sep 2024 //
GLOBENEWSWIRE
Helius Medical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16 Aug 2024 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
12 Aug 2024 //
GLOBENEWSWIRE
Helius Medical To Release Q2 2024 Results On August 12
06 Aug 2024 //
GLOBENEWSWIRE
Helius Completes Site Enrollment For U.S. Stroke Registrational Program
17 Jun 2024 //
GLOBENEWSWIRE
Helius Gets Third-Party Reimbursement For PoNS® From Major Insurer
29 May 2024 //
GLOBENEWSWIRE
Helius Pons Ms Progress: Cmsc 2024 Exhibit Marking Availability
23 May 2024 //
GLOBENEWSWIRE
Helius PoNS Now Available On VA FSS, GSA Advantage
20 May 2024 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
13 May 2024 //
GLOBENEWSWIRE
Helius Medical Q1 2024 Results On May 13
10 May 2024 //
GLOBENEWSWIRE
Helius PoNS Device Gets Preliminary CMS Reimbursement Determination
06 May 2024 //
GLOBENEWSWIRE
Helius Medical Prices $6.4M Public Offering
06 May 2024 //
GLOBENEWSWIRE
Helius Expands Stroke Program with Shepherd Center
24 Apr 2024 //
GLOBENEWSWIRE
Helius Announces Partner with Lovell Govt Services for Reach of PoNS Therapy
03 Apr 2024 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. Reports Q4 & FY23 Financial Results
28 Mar 2024 //
GLOBENEWSWIRE
Helius Medical to Release Fourth Quarter and Full Year 2023 Financial Results
15 Mar 2024 //
GLOBENEWSWIRE
Helius Medical Initiates Open-Label Study for Registrational Program in Stroke
12 Mar 2024 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
07 Mar 2024 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. Secures HCPCS Codes for PoNS
04 Mar 2024 //
GLOBENEWSWIRE
Helius Medical Announces Alignment with FDA on Registrational Program
06 Feb 2024 //
GLOBENEWSWIRE
Helius Booth Combined Sections Meeting Will Highlight Therapists Ability
05 Feb 2024 //
GLOBENEWSWIRE
Helius Medical Announces Further Expansion of Stroke Clinical Program
11 Jan 2024 //
GLOBENEWSWIRE
Helius Medical Technologies to Present at NobleCon19 Annual Conference
30 Nov 2023 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Helius Announces Study Results Demonstrating That PoNS Therapy Helps Patients
06 Nov 2023 //
GLOBENEWSWIRE
Helius Medical Technologies to Release Third Quarter 2023 Financial Results
02 Nov 2023 //
GLOBENEWSWIRE
Helius Medical Receives Letter of Intent from the Québec Ministry of Health
12 Oct 2023 //
GLOBENEWSWIRE
Helius Technologies to Participate at Two Upcoming Healthcare Conferences
02 Oct 2023 //
GLOBENEWSWIRE
Helius Receives UPC Numbers for its PoNS® System and Mouthpiece
28 Sep 2023 //
GLOBENEWSWIRE
Helius to Bring its Innovative PoNS Therapy for Improvement of Gait
21 Sep 2023 //
GLOBENEWSWIRE
Helius Medical Compliant with All Applicable Nasdaq Listing Criteria
05 Sep 2023 //
GLOBENEWSWIRE
Helius Medical Technologies Announces Reverse Stock Split
16 Aug 2023 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Helius Announces Participation of Montefiore Medical in Therapeutic Program
07 Aug 2023 //
GLOBENEWSWIRE
Helius Medical to Release Q2 2023 Financial Results on August 10, 2023
02 Aug 2023 //
GLOBENEWSWIRE
Helius Medical Expands Stroke Trial at the Medical University of South Carolina
27 Jul 2023 //
GLOBENEWSWIRE
Helius Medical Technologies Announces DMEPOS Accreditation for PoNS
20 Jun 2023 //
GLOBENEWSWIRE
Helius Medical Technologies to Participate in the Healthcare Virtual Conference
14 Jun 2023 //
GLOBENEWSWIRE
Helius to Highlight Innovative PoNS Therapy at the 2023 of Multiple Sclerosis
24 May 2023 //
GLOBENEWSWIRE
Helius Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19 May 2023 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Helius Medical Technologies, Inc. to Release 1Q 2023 FYR on May 11, 2023
04 May 2023 //
GLOBENEWSWIRE
Helius Medical to Spotlight Expanded Authorizations for its PoNS Device
17 Apr 2023 //
GLOBENEWSWIRE
Helius Medical Technologies Announces Distribution of Series B Preferred Stock
23 Mar 2023 //
GLOBENEWSWIRE
Helius Medical Technologies and HealthTech Connex Announce Agreement
22 Mar 2023 //
GLOBENEWSWIRE
Helius Announces Authorization from Health Canada to Market PoNS
09 Mar 2023 //
GLOBENEWSWIRE
Helius Reports Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Helius to Release Q4 and Full Year 2022 Financial Results on March 9, 2023
06 Mar 2023 //
GLOBENEWSWIRE
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
02 Mar 2023 //
GLOBENEWSWIRE
Helius Medical to Showcase PoNS Therapy at American Physical Therapy Association
15 Feb 2023 //
GLOBENEWSWIRE
